Multiplex, DNase-free one-step reverse transcription PCR for Plasmodium 18S rRNA and spliced gametocyte-specific mRNAs. by Hanron, Amelia E et al.
Hanron et al. Malar J  (2017) 16:208 
DOI 10.1186/s12936-017-1863-3
RESEARCH
Multiplex, DNase-free one-step reverse 
transcription PCR for Plasmodium 18S rRNA 
and spliced gametocyte-specific mRNAs
Amelia E. Hanron1, Zachary P. Billman1,3, Annette M. Seilie1, Tayla M. Olsen1, Matthew Fishbaugher4, 
Ming Chang1, Thomas Rueckle5, Nicole Andenmatten5, Bryan Greenhouse6, Emmanuel Arinaitwe7,8, 
John Rek7, Smita Das9, Gonzalo J. Domingo9, Kelly Shipman10, Stefan H. Kappe4, James G. Kublin10 
and Sean C. Murphy1,2,3,4*
Abstract 
Background: Plasmodium gametocytes are sexual stages transmitted to female Anopheles mosquitoes. While 
Plasmodium parasites can be differentiated microscopically on Giemsa-stained blood smears, molecular methods 
are increasingly used because of their increased sensitivity. Molecular detection of gametocytes requires methods 
that discriminate between asexual and sexual stage parasites. Commonly tested gametocyte-specific mRNAs are 
pfs25 and pfs230 detected by reverse transcription polymerase chain reaction (RT-PCR). However, detection of these 
unspliced mRNA targets requires preceding DNase treatment of nucleic acids to eliminate co-purified genomic DNA. 
If gametocyte-specific, spliced mRNAs could be identified, DNase treatment could be eliminated and one-step multi-
plexed molecular methods utilized.
Results: Expression data was used to identify highly-expressed mRNAs in mature gametocytes that were also low in 
antisense RNA expression in non-gametocyte stages. After testing numerous candidate mRNAs, the spliced female 
Pf3D7_0630000 mRNA was selected as a Plasmodium falciparum gametocyte-specific biomarker compatible with 
Plasmodium 18S rRNA RT-PCR. This mRNA was only detected in samples containing mature gametocytes and was 
absent in those containing only asexual stage parasites or uninfected human blood. PF3D7_0630000 RT-PCR detected 
gametocytes across a wide range of parasite densities in both spiked and clinical samples and agreed with pfs25 RT-
PCR, the gold standard for RT-PCR-based gametocyte detection. PF3D7_0630000 multiplexed with Plasmodium 18S 
rRNA RT-PCR was more sensitive than other spliced mRNA targets for one-step RT-PCR gametocyte detection.
Conclusions: Because the spliced target does not require DNase treatment, the PF3D7_0630000 assay can be multi-
plexed with Plasmodium 18S rRNA for direct one-step detection of gametocytes from whole human blood.
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Background
Plasmodium gametocytes are the male and female sexual 
stages of the parasite responsible for transmission from 
an infected host into the female Anopheles mosquito 
vector. While gametocytes do not directly cause clinical 
disease in the mammalian host, their presence denotes 
potential continued transmission. Mature gameto-
cytes circulate in peripheral blood for 3 weeks or longer 
[1–4]. The frequency and density of gametocyte car-
riage is correlated with the likelihood that mosquitoes 
will become infected after taking a blood meal [5–7]. 
Persons with sub-microscopic Plasmodium falciparum 
gametocyte densities can contribute to transmission [2, 
7–9] with transmission possible at densities as low as 
250–300 gametocytes/mL of blood [9]. Thus, gametocyte 
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detection strategies should ideally be able to achieve this 
level of analytical sensitivity.
Gametocytes can be identified by light microscopy of 
Giemsa-stained thick and thin blood smears but, like all 
microscopic methods for Plasmodium parasites, only to a 
density of  ~5000–20,000 parasites/mL (5–20/μL) by thick 
blood smear [10]. Molecular methods are more sensitive 
and include qualitative or quantitative RT-PCR [3, 11–14] 
and NASBA [9, 15, 16]. mRNA-based methods are used 
to differentiate gametocytes from asexual stages by detect-
ing stage-specific mRNAs. The most common gametocyte 
mRNA targets are pfs25 [17, 18] and pfs230 [18–20] for P. 
falciparum and pvs25 for P. vivax [17]. These well-studied 
targets are all derived from unspliced mRNAs, so a DNase 
treatment step is required to destroy genomic DNA prior to 
RT. When manual DNase treatment is performed, there is 
partial loss of sample material and increased risk for sample 
cross-contamination due to added handling steps. DNase 
treatment also makes the process more time consuming. 
For detection of asexual stage parasites, some laborato-
ries already perform one-step multiplex Plasmodium 18S 
rRNA RT-PCR directly from extracted whole blood without 
DNase treatment [21, 22]. In these assays, DNase treatment 
is not required because Plasmodium 18S rRNAs are more 
than three orders of magnitude more abundant than the 
coding 18S rDNA genes [21, 22]. Plasmodium 18S rRNAs 
are developmentally regulated between sexual and asexual 
stages [23–25] but gametocytes express both S- (sexual) and 
A- (asexual)-type 18S rRNAs [18]. Because of this expres-
sion, 18S rRNAs alone cannot be used to differentiate game-
tocytes from asexual stage parasites. Spliced mRNAs that 
were highly expressed in gametocytes and showed nearly 
absent antisense RNA expression in the asexual stage were 
hypothesized to be ideal targets for multiplexing with the 
Plasmodium 18S rRNA assay for one-step RT-PCR Plas-
modium detection. Although three spliced gametocyte-
expressed mRNAs have been reported as RT-PCR targets 
[26, 27], it was unknown whether these targets were suitable 
for multiplexing with the 18S rRNA assay.
Here, bioinformatic methods were used to search for 
spliced, gametocyte-specific mRNA targets compatible 
with one-step Plasmodium 18S rRNA RT-PCR methods. 
After testing candidate targets and identifying several 
gametocyte-specific spliced mRNAs, the PF3D7_0630000 
mRNA was selected as a P. falciparum-specific spliced 
mRNA for RT-PCR without DNase treatment. This novel 
mRNA target was then tested against pfs25 and a known 
spliced mRNA using clinical samples.
Methods
Bioinformatics
mRNA expression fold-change from Lopez-Barragan 
et al. [28] was evaluated. Fold-change data was summed 
for asexual or gametocyte stages, sorted and filtered 
to remove mRNAs with total asexual expression  ≥0 or 
total gametocyte expression ≤0 (all relative to ring stage 
expression). Single exon genes were eliminated as were 
those lacking data in http://www.plasmodb.org and those 
representing redundant mRNA isoforms. Fold change 
data in [28] were based on RNASeq reads per kilobase 
of exon per million (RPKM). Since RPKM can originate 
from sense or antisense transcripts, the strand-specific 
fragments per kilobase of exon per million (FPKM) [28] 
were also inspected, and genes with schizont antisense 
FPKM equal to 50–100% of maximum were eliminated 
as were those with minimum asexual antisense FPKM 
within twofold of the maximum gametocyte antisense 
FPKM values. Remaining genes were sorted on stage V 
gametocyte expression, and the most highly expressed 
genes were evaluated for suitable intron-spanning splice 
RT-PCR designs. RPKM and FPKM data deposited in 
plasmodb.org from [28] for selected genes is in Addi-
tional file 1.
Primer/probes
Primers and probes were designed to target exons using 
the web-based PrimerQuest tool (http://www.idtdna.
com/Primerquest/). Primers were commercially synthe-
sized (IDT DNA, Coralville, IA, USA); primer set names 
(S1, S2, S3, etc.) were arbitrarily assigned by the IDT 
PrimerQuest software.
Plasmodium falciparum cultures
Asexual stage Plasmodium parasites were cultured as 
described [21]. Gametocytes were cultured as described 
[29]. Purity of cultures was confirmed by microscopy. 
Some asexual stage cultures were further confirmed 
gametocyte-free by pfs25 RT-PCR.
Human clinical samples
Leftover clinical whole blood specimens (50  μL) were 
preserved in 2 mL of NucliSens Lysis Buffer (bioMérieux, 
Marcy-l’Étoile, France). These samples were used under a 
protocol approved by the University of Washington Insti-
tutional Review Board (IRB) (protocol 47026, S. Murphy). 
Samples were included from a clinical trial of a novel 
chemical entity DSM265 approved under Fred Hutchin-
son Cancer Research Center IRB (protocol 8408, J. Kub-
lin). Samples from a field study in Uganda were collected 
from consenting study participants or with the assent of 
children and consenting legal care givers within the con-
text of studies approved by the relevant IRBs. Specimens 
from Nagongera, Tororo District, Uganda were collected 
under a study approved by the University of California 
San Francisco IRB 11-05995 and Uganda IRB 2011-0167. 
In Uganda, EDTA whole blood samples were collected 
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from a previously described surveillance cohort [30]; all 
participants provided informed consent. Samples from 
Uganda were collected from May to October 2015.
Nucleic acid extraction
Nucleic acids were extracted on a bioMérieux EasyMAG 
[21] or an Abbott m2000sp as described [22]. Briefly, on 
the bioMérieux instrument, 1  mL of the 2.05  mL lysed 
sample (50  µL whole blood plus 2  mL NucliSENS lysis 
buffer) was extracted for total nucleic acids and eluted 
into 40  µL of elution buffer. On the Abbott m2000sp 
instrument, 1  mL of the 2.05  mL lysed sample was 
extracted preferentially for RNA and eluted into 53 μL of 
elution buffer.
RT‑PCR
In initial studies of candidate primers, singleplex RT-
PCR was performed using the AgPath mastermix kit as 
described by the manufacturer (Thermo Fisher Scientific, 
Waltham, MA) in the presence of LCGreen DNA-binding 
dye as described by the manufacturer (BioFire, Salt Lake 
City, UT). Some such RT-PCR products were evaluated by 
1.5% agarose gel electrophoresis. For multiplex studies of 
spliced mRNA targets with 18S rRNA, pan-Plasmodium 
18S rRNA RT-PCR was performed as described [31] with 
the addition of the candidate spliced gametocyte primers 
(200 nM) and probe (100 nM) on an Abbott m2000rt or 
Bio-Rad C1000 (Bio-Rad, Hercules, CA). Briefly, 15 µL of 
eluate was combined with 35 µL of mastermix as described 
in the SensiFAST LO-ROX one step RT-PCR kit product 
manual (Bioline, Tauton, MA). Cycling conditions were 
reverse transcription 10 min at 48 °C, 95 °C for 2 min fol-
lowed by 45 cycles of 95 °C for 5 s followed by 50 °C for 35 s. 
For pfs25/18S rRNA multiplex RT-PCR, total nucleic acids 
were DNase treated (TURBO DNA-free Kit, Ambion/
Life) and pfs25 and 18S rRNA RT-PCR performed using 
published cycling conditions and concentrations of Plas-
modium 18S rRNA primers/probe [31] supplemented 
with pfs25 primers (400  nM) and probe (200  nM) [17]. 
Reagents for a gametocyte-specific mRNA from P. falci-
parum meiotic recombination protein DMC1-like pro-
tein gene (PF3D7_0816800) were as previously reported 
[26]: forward 5′-ATATCGGCAGCGAAAATGTGT-3′; 
reverse 5′-GACAATTCCCCTCTTCCACTGA-3′; probe 
5′-(6-FAM)-TGCCCTTCTCGTAGTTGATTCGATTATT
(BHQ1)-3′. Reagents for the early/mid- (PF3D7_1477700/
PF14_0748) and mid/late-gametocyte expressed mRNAs 
(PF3D7_1438800/PF14_0367) were as previously reported 
[27]: PF3D7_1477700: forward 5′-CTTATGTGCTGAATT 
TTGTGTTATGGT-3′, reverse 5′-TTGGCCACACTGCT 
CTAGGA-3′, probe: 5′(VIC)-CACATAATGAATTCA
AGGGTAG(MGBNFQ)-3′; PF3D7_1438800: forward 
5′- GTTACATTTCGACCCAGCATAAATT-3′, reverse 
5′-TCCCTGTGTTTTTGCTCATCTTC-3′, probe 5′-(VIC)- 
CAGTGCATATTGTTGCCTGT(MGBNFQ)-3′. All probes 
were 6-FAM-labelled and sourced from IDT (Coral-
ville, IA) with the exceptions of the CAL Fluor orange 
560-labeled pan-Plasmodium 18S rRNA hydrolysis probe 
(LCG Biosearch Technologies, Novato, CA) and the VIC-
labeled PF3D7_1477700 and PF3D7_1438800 probes (Inv-
itrogen). Where indicated, some reactions were tested at 
other annealing temperatures to investigate specificity. 
Quantification of parasites was achieved using an abso-
lute 18S rRNA standard curve as described [22, 31], which 
allowed estimation of gametocyte-specific assay limits of 
detection (LOD). For gametocyte markers evaluated using 
whole parasite standard curves,  CT values up to 40.0 cycles 
were converted into quantitative values.
Statistics
To evaluate unlysed sample stability, an unpaired t test 
was used to compare mean  CT values for 18S rRNA and 
gametocyte-specific markers and the difference in these 
 CT values. For sensitivity analyses, exact confidence 
intervals were calculated [32]. Statistical significance for 
both was P < 0.05.
Results
Target selection
One-thousand one-hundred twenty-nine genes evalu-
ated previously by RNAseq [28] were filtered to remove 
those with increased asexual expression (sum of asexual 
fold change  ≥0) and decreased gametocyte expression 
(sum of stage II and V gametocyte fold change ≤0). This 
resulted in 372 genes with gametocyte stage II and/or 
V expression and an absence of asexual-stage expres-
sion. The most well-known gametocyte target pfs25 
(PF3D7_1031000) was one of the most highly expressed 
gametocyte-specific genes in this set (Additional file  1). 
Six genes were eliminated because they lacked data in 
plasmodb.org and all single exon genes were also elimi-
nated. Two-hundred genes contained two or more exons. 
Since antisense transcripts are produced for many Plas-
modium genes [28] and since such transcripts can lead to 
false positive results in primer-specific RT-PCRs [33–36], 
antisense strand-specific FPKM data [28] were evalu-
ated next. Genes with low or absent antisense transcript 
expression in non-gametocyte stages were retained (48 
genes), sorted on stage V gametocyte expression and 
evaluated for intron-spanning primer/probe designs 
compatible with the Plasmodium 18S rRNA RT-PCR 
cycling temperatures. RT-PCR designs for 14 genes were 
ultimately selected using this strategy as were designs for 
four additional genes overexpressed in stage II/V game-
tocytes but not identified by published fold-change data 
in [28]; published RT-PCRs for pfs25 and three reported 
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multi-exon gametocyte-specific genes [26, 27] were also 
included (Additional file 1). Based on recently published 
data [37], two genes were male-specific (PF3D7_1477700, 
PF3D7_1438800), one showed mixed expression 
(PF3D7_1020100) and the rest were female-specific 
(Additional file 1).
RT‑PCR with LCGreen intercalating dye for candidate 
targets
LCGreen RT-PCR was performed on 27 target regions 
of the 18 novel genes of interest using total nucleic 
acids obtained from either cultured mature P. falcipa-
rum gametocytes or from cultured synchronized ring-
stage asexual parasites (Additional file  2). Although 
these RT-PCR assays do not provide absolute quanti-
fication, the difference (Δ) between  CT values for the 
18S rRNA and the mRNA of interest provide an esti-
mate of spliced mRNA abundance. In cultured samples 
enriched for mature gametocytes, gametocyte-specific 
spliced mRNAs were detected 6.9–25.2 cycles later than 
Plasmodium 18S rRNA (ΔCT Gam mRNA–18SrRNA). In cul-
tured samples containing only asexual-stage parasites, 
the ΔCT iRBC mRNA–18SrRNA was typically larger than the 
aforementioned ΔCT Gam mRNA–18SrRNA for each candidate 
mRNA, as expected for gametocyte-expressed mRNAs 
(Additional file  2). mRNAs with the smallest ΔCT Gam 
mRNA–18SrRNA and the largest ΔCT iRBC mRNA–18SrRNA were 
considered to represent the best balance between high 
and specific gametocyte expression. Gel electrophoresis 
was used to evaluate some RT-PCR products. For exam-
ple, for PF3D7_0630000, a band of the expected size 
(141 bp) was only generated in the presence of gameto-
cytes by RT-PCR (Fig. 1a). The probe for this target was 
designed to span an intron (Fig. 1b).
Probe‑based RT‑PCR
Four primer sets that specifically detected gametocytes 
by LCGreen, had RT-PCR efficiencies of 90–110% and 
had probe melting temperatures compatible with the 18S 
rRNA RT-PCR [PF3D7_0514500 (S1), PF3D7_0518800 
(S1), PF3D7_0630000 (S3), PF3D7_1214500 (S1)] were 
further evaluated using hydrolysis probes (Table 1). These 
RT-PCRs detected gametocyte mRNA in gametocyte-
containing samples (Fig.  2). However, PF3D7_1214500 
(S1) reacted with some parasite-negative human blood 
samples and PF3D7_1214500 (S1) and PF3D7_0518800 
(S1) occasionally gave false positives for blood from 
microscopically-pure cultured asexual-stage parasites, so 
further study of these targets was discontinued. Positive 
 CTs for PF3D7_0630000 (S3) RT-PCR were ~2–4 cycles 
earlier than for PF3D7_0514500 (S2) so PF3D7_0630000 
was prioritized for development.
PF3D7_0630000‑specific qRT‑PCR
PF3D7_0630000 (aliases MAL6P1.128 and PFF1455c) 
encodes a CPW-WPC family protein. CPW-WPC protein-
coding mRNAs are expressed and post-transcriptionally 
regulated in gametocytes and later translated into surface 
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Fig. 1 Specific amplicon produced by RT-PCR targeting gametocyte-specific spliced PF3D7_0630000 mRNA. a RT-PCR was performed with (+RT) 
and without (−RT) reverse transcriptase on nucleic acids extracted from mature gametocytes (GAM) or from asexual-stage infected red blood cells 
(ASEX) and products were separated by 1% agarose gel electrophoresis. a 100 bp ladder is shown at left. b PF3D7_0630000 mRNA
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proteins in ookinetes [38]. The PF3D7_0630000 (S3) rea-
gents target exons 3–6 of the mature mRNA with the 
probe and reverse primer spanning introns 4 and 5, respec-
tively (Fig. 1b). The spliced mRNA amplicon was 141 bp. 
Nucleic acids from a dilution series of mature gametocytes 
(Day 14 of culture) were tested using RT-PCRs for Plasmo-
dium 18S rRNA, PF3D7_0630000 and pfs25 to generate a 
standard curve and evaluate assay efficiency and linearity 
Table 1 Candidate primer/probe combinations evaluated for gametocyte-specific targets
Gene ID # Exons Exons 
targeted
Forward primer Probe (±strand) Reverse primer
PF3D7_1214500 (S1) 6 2–4 TGGGATGATGAATATGAAG TGGAACTGGTTCGCTATATTGT  (−) AAAGGTCTATTAGTTGAATTG
PF3D7_0630000 (S3) 10 3–6 AACGCAGAAATAGAAAATC TGGTATATTGGGAAGTGTAGAAGAG  (+) GTCATAAGCAGATACATTC
PF3D7_0514500 (S2) 6 2–3 GATAAGACAAAACGGAAC CACAGGAGTAGTGACCATATCAG   (+) CTATAAGGAAAAGATAACAAAG
PF3D7_0518800 (S1) 7 1–2 GCCGTTACTGATTCCTTAC TGTCTGAGTTACGACAAGAAATTAG (+) CGAGAATACCCATTTGTC
PF3D7_1031000/pfs25 1 1 GAAATCCCGTTTCATACGCTTG TGTAAGAATGTAACTTGTGGTAACG 
GT  (+)
AGTTTTAACAGGATTGCTTGTA 
TCTAA
Pf3D7_0514500 (S2)
Pf3D7_0518800 (S1)
Pf3D7_0630000 (S3)
Pf3D7_1214500 (S1)
18S rRNA
18S rRNA
18S rRNA
18S rRNA
18S rRNA
18S rRNA
18S rRNA
18S rRNA
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PF3D7_0518800
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PF3D7_1214500
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18S CT = 26.6
Candidate CT = ND
18S CT = 27.2
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Fig. 2 Specific detection of spliced gametocyte-specific mRNAs by hydrolysis probe RT-PCR. RT-PCR was performed using hydrolysis probes for the 
four spliced gametocyte-specific targets listed on nucleic acids extracted from asexual-stage infected red blood cells (left panels) or from mature 
gametocytes (right panels). Reactions were multiplexed with a primer/probe set for the Plasmodium 18S rRNA. Horizontal lines denote the RT-PCR 
thresholds used to calculate  CT values (lower green line 18S rRNA; upper blue line candidate mRNA). Y-axis, RFU (raw fluorescence units) from Biorad 
C1000/CFX instrument. ND not detected
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(Fig.  3a; Table  2). Plasmodium 18S rRNA qRT-PCR was 
able to quantitatively detect as few as 30 parasites/mL of 
whole blood, consistent with the assay limit of detection 
of 20 parasites/mL; the  CT curve generated for the most 
dilute sample was below the assay limit of quantification. 
Probe-based qRT-PCR for pfs25 and PF3D7_0630000 
detected gametocytes from 3  ×  107 to 3  ×  102 para-
sites/mL, and pfs25 additionally detected parasites at the 
3  ×  101 parasites/mL dilution. PF3D7_0630000 mRNA 
was never detected in samples containing asexual-stage 
parasites (even at high parasite densities) confirming that 
this spliced target is absent from asexual stages. All reac-
tions demonstrated high cycling efficiencies (Fig.  3b: 18S 
rRNA slope −3.14, efficiency 108%, y-intercept: 29.4 
cycles; pfs25 slope −3.32, efficiency 100%, y-intercept 
35.71 cycles; PF3D7_0630000 slope −3.59, efficiency 90%, 
y-intercept 42.67 cycles). Consistent with RNAseq data 
[28], PF3D7_0630000 was less abundant than pfs25, and 
both mRNAs were much less abundant than the highly 
expressed Plasmodium 18S rRNA.
PF3D7_0630000 mRNA stability
To assess spliced mRNA target stability, intact gameto-
cytes in whole blood were either preserved in lysis buffer 
immediately or held at room temperature for 3–7  days 
before processing into lysis buffer. For all samples (nomi-
nal densities 3 × 102–3 × 105 gametocytes/mL), mRNA 
(pfs25 and PF3D7_0630000) degradation was observed 
at 3 and 7 days of storage, whereas statistically significant 
18S rRNA degradation was not observed until 7 days of 
storage (Fig.  4). PF3D7_0630000 degraded more rapidly 
than pfs25 at 3 days but this difference was not statisti-
cally different at 7  days. These data suggest, while sam-
ples for 18S rRNA testing can be stored for several days 
prior to sample processing, samples for gametocyte-spe-
cific pfs25 or PF3D7_0630000 mRNA testing should be 
processed immediately following collection.
Kinetics of PF3D7_0630000 mRNA expression
To study the time course of PF3D7_0630000 expres-
sion, samples were taken from gametocyte cultures dur-
ing Days 6–14 of culture and compared to expression of 
the Day 6 sample. This approach was used because on 
the sixth day of culture, a mix of residual asexual stages 
and immature gametocytes present, but after the tenth 
day of culture, most of the parasites were mature game-
tocytes with ring, trophozoite and schizont stages no 
longer observed. Unlike asexual-stage parasites that do 
not express the PF3D7_0630000 spliced mRNA, game-
tocytes express both pfs25 and PF3D7_630000 mRNAs 
from by the sixth day of culture. Expression of both tar-
gets increased as the cultures matured with pfs25 expres-
sion exceeding that of PF3D7_0630000 (Fig. 5). At peak 
expression (day 14), pfs25 was increased by  >2000-fold 
compared to day 6 of culture while PF3D7_0630000 
increased >25-fold.
Detection of gametocytaemia in a volunteer in a controlled 
human malaria infection trial
To determine if the novel spliced gametocyte-specific 
mRNA RT-PCR could detect low level gametocytaemia 
from clinical specimens, samples were first evaluated 
from a clinical trial in a Seattle-based controlled human 
malaria infection trial evaluating the prophylactic activity 
of the drug DSM265. This placebo-controlled prophylactic 
drug trial was blinded at the time of this manuscript, and 
it was thus unknown whether subjects received the active 
compound or the placebo control. Subjects were chal-
lenged with 3200 PfSPZ (Sanaria, Inc., Rockville, MD) on 
Day 0. Final details of the ongoing DSM265 study will be 
published in a separate manuscript at a later date and do 
not affect the data described below. Plasmodium infection 
status was monitored by daily 18S rRNA RT-PCR. One 
subject developed a late onset infection with 18S rRNA 
qRT-PCR positivity starting on Day 23 (Fig. 6). The subject 
was symptomatic (grade 1–2 nausea, vomiting, headache) 
during this time and was thick blood smear positive on Day 
25. The subject was treated on Day 25 with atovaquone–
proguanil with rapid conversion to negative blood smears 
and resolution of symptoms. Plasmodium 18S rRNA con-
centrations dropped following treatment but did not reach 
undetectable levels. On Day 33 post-challenge, resurgence 
in Plasmodium 18S rRNA was noted although the subject 
was asymptomatic. Persistent asymptomatic positivity for 
Plasmodium 18S rRNA continued from days 33–42 post-
challenge. Neither pfs25 nor PF3D7_0630000 mRNAs 
were detected during the symptomatic period but both 
were detected during the second wave of asymptomatic 
parasitaemia (Fig. 6). The patient was subsequently treated 
orally with 45 mg primaquine and was negative for all bio-
markers at 56 days post-challenge.
Multiplex comparison against other reported 
gametocyte‑specific spliced mRNA targets
In addition to PF3D7_0630000, three other spliced 
mRNA targets have been reported: the P. falciparum 
meiotic recombination protein DMC1-like protein 
gene (PF3D7_0816800) [26], an immature gametocyte 
marker PHISTa of unknown function (PF3D7_1477700/
PF14_0748) [27] and a mature gametocyte marker of 
unknown function (PF3D7_1438800/PF14_0367) [27]. 
Each of these targets were individually multiplexed with 
the pan-Plasmodium 18S rRNA assay and tested against 
whole blood samples spiked with high (4 × 105 parasites/
mL) or low (8  ×  102) density pure cultured ring-stage 
samples or with day 14 cultured gametocytes (Table  3). 
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The PF3D7_1477700 and PF3D7_1438800 markers [27] 
could not be successfully multiplexed with the pan-Plas-
modium 18S rRNA RT-PCR because false positive results 
were obtained for asexual samples at annealing tempera-
tures of 50 °C (standard for 18S rRNA RT-PCR) and 60 °C 
(as originally reported for these gametocyte markers 
18S rRNA
PF3D7_0630000
pfs25 (DNase-treated)
Cycle
∆R
n
a
b
0 10 20 30 403525155 45
0 10 20 30 403525155 45
0 10 20 30 403525155 45
0
10
20
30
40
1 3 5 7
C T
Esmated log10 gametocytes/mL
Pf3D7-0630000
18S rRNA
pfs25
1.0
0.8
0.6
0.4
0.2
0
-0.2
2.0
1.5
1.0
0.5
0
-0.5
2.5
2.0
1.5
1.0
0.5
0
-0.5
Fig. 3 Dilution series of gametocytes tested by RT-PCR for 18S rRNA, Pf3D7_0630000 and pfs25. a RT-PCR was performed with hydrolysis probes 
on nucleic acids from enriched gametocyte cultures diluted into whole human blood across the range of parasite densities indicated in the figure 
(3 × 107 gametocyte/mL blood to 3 gametocytes/mL blood). Samples for 18S rRNA and PF3D7_0630000 were not treated with DNase; samples for 
pfs25 RT-PCR were DNase treated as required for an unspliced target. DNase-treated 18S rRNA  CT values were comparable to non-DNase-treated  CTs 
indicating that little to no 18S rRNA was lost in the DNase treatment (data not shown). Duplicates shown with Y-axis = ΔRn (change in fluores-
cence) from the Abbott m2000rt instrument. Labels indicate estimated parasite densities in parasites/mL (see Table 2 for  log10 values used in panel 
b. b Linear regression was performed using nominal  log10 transformed parasite densities and mean  CTs (error bars 95% confidence intervals for 
available duplicate samples) to generate standard curves for the enriched gametocyte material
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[27]). False positive results for the PF3D7_1477700 and 
PF3D7_1438800 markers were also obtained when test-
ing singleplex reactions against asexual stage parasites 
(data not shown). PF3D7_0630000 and pfs25, the spliced 
PF3D7_0816800 target were positive only in the presence 
of gametocytes (Table 3).
One‑step multiplex detection of gametocytes 
in asymptomatic subjects in Uganda
Multiplex qRT-PCRs combining Plasmodium 18S 
rRNA with either PF3D7_0816800, PF3D7_0630000 or 
pfs25 were evaluated against 74 Plasmodium-infected 
samples collected from asymptomatic human volun-
teers in a Ugandan field study. The parasite densities of 
these samples ranged from 25 to 2.8  ×  107 parasites/
mL with estimated gametocyte densities ranging from 
1 to 156,828 gametocytes/mL (based on pfs25 standard 
curves). The pfs25 multiplex assay detected gameto-
cytes in 47/74 samples, PF3D7_0630000 in 50/74 sam-
ples and PF3D7_0816800 in 30/74 samples (Additional 
file 3). pfs25 and PF3D7_0630000 showed a high degree 
of agreement. Compared to the pfs25 gold standard, the 
sensitivity of PF3D7_0630000 for gametocyte detection 
was 97.9% (95% CI 88.7–100.0%) and specificity 85.2% 
(95% CI 66.3–95.8%). The sensitivity of PF3D7_0816800 
qRT-PCR was 63.8% (95% CI 48.5–77.3%) and specific-
ity 100% (87.2–100.0%). Whereas the PF3D7_0630000 
reagents detected gametocytes across all pfs25-positive 
gametocyte densities, PF3D7_0816800 RT-PCR was less 
sensitive at densities  <1000 gametocytes/mL but was 
positive in all samples with a density of  >1000 gameto-
cytes/mL (Table 4; Fig. 7).
Quantification of gametocytes in field samples based on 
pfs25 resulted in estimated densities 1.18  log10 parasites/
mL (95% CI 0.89–1.46  log10 parasites/mL) lower on aver-
age than the paired estimates made with PF3D7_0630000. 
Lower pfs25-derived gametocyte quantification could not 
be explained by overall loss of total nucleic acids during 
DNase treatment since 35/39 evaluable paired samples 
(positive by pfs25 and PF3D7_0630000) actually showed 
earlier 18S rRNA  CTs in the pfs25 sample compared to 
the PF3D7_0630000 sample (Additional file 3).
Discussion
Plasmodium gametocytes can be detected with mRNA-
based molecular methods at sub-microscopic densities. 
Commonly targeted gametocyte-specific P. falciparum 
mRNAs include those made from single exon genes pfs25 
and pfs230 [17–20], which necessitates DNase treatment 
prior to RT-PCR. Here, based on published RNAseq data 
[28], 18 gametocyte-specific, multi-exon mRNAs were 
identified and evaluated as DNase-free gametocyte tar-
gets to determine if they could be multiplexed with an 
existing highly sensitive Plasmodium 18S rRNA qRT-
PCR. The bioinformatics strategy employed here selected 
for genes that were highly expressed in mature gameto-
cytes and showed near-zero sense or antisense expres-
sion in asexual stages. In wet-lab testing, two female 
gametocyte-specific mRNAs showed suitable multiplex 
RT-PCR target characteristics: PF3D7_0630000 and 
PF3D7_0514500. PF3D7_0630000 encodes a CPW-WPC 
protein likely expressed in ookinetes, though the coding 
mRNAs are first expressed and post-transcriptionally 
regulated in gametocytes [38]. Since the PF3D7_0630000 
Table 2 Cycle thresholds for  Plasmodium 18S rRNA, 
PF3D7_0630000 and pfs25 in gametocyte dilution series
Plasmodium 18S rRNA RT-PCR LOD = 20 parasites/mL
ND, not detected; All in duplicate except 3 × 107 gametocyte/mL sample
Gametocytes/mL Plasmodium 18S rRNA PF3D7_0630000 pfs25
3 × 107 5.40 15.70 10.53
3 × 106 9.36 19.70 14.48
8.85 19.38 13.94
3 × 105 12.16 23.13 17.91
12.34 22.98 17.42
3 × 104 15.12 26.47 20.70
15.11 26.50 20.65
3 × 103 18.14 29.43 23.60
18.63 29.60 23.99
3 × 102 21.85 33.86 27.74
21.82 33.65 27.92
3 × 101 24.06 37.89 30.35
ND ND ND
3 × 100 ND ND ND
ND ND ND
Immediate Day 3 Day 7
**
****
*
ns
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Fig. 4 Stability of the PF3D7_0630000 mRNA compared to that of 
pfs25 and 18S rRNA. Samples were tested across a range of parasite 
densities (3 × 102–3 × 105 parasites/mL) and the mean change in 
estimated gametocyte concentration was assessed after variable stor-
age times. Error bars show 95% CI; n = 8 samples for Days 0 and 3 and 
n = 3 samples for day 7
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mRNA accumulates in mature female gametocytes 
as the parasite awaits ookinete formation, this target 
may be an ideal gametocyte marker in human blood. 
PF3D7_0514500 (alias PFE0725C) encodes a six-exon 
conserved membrane protein of unknown function and 
was noted to be a member of the sexual development 
gene cluster in a previous full-genome high-density 
oligonucleotide microarray study [39]. Interestingly, 
PF3D7_0630000 was absent from the same gene cluster 
study.
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Fig. 5 Time course of mRNA expression in cultured gametocytes. Gametocytes were cultured and equal volume and equal hematocrit samples 
were removed at the indicated time points and evaluated by Giemsa-stained thin smear microscopy (top) and RT-PCR (bottom) for the three 18S 
rRNA, PF3D7_0630000 and pfs25 targets. Duplicate samples were tested for 18S rRNA (black squares) and PF3D7_0630000 (red diamonds) with 95% 
CIs indicated; singlet samples were tested for positive control gametocyte marker pfs25 (grey triangles). Fold change was calculated for each target 
as the ratio of the expression on the day of interest relatives to expression of the same target on Day 6 of gametocyte culture
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Fig. 6 Course of molecular target detection in infected subject. A patient infected with P. falciparum by CHMI developed late-onset, symptomatic, 
blood-smear positive (D25) peripheral infection and was treated 25 days post-challenge with a standard treatment course of atovaquone–progua-
nil (A/P). Following treatment, symptoms resolved but the patient continued to display 18S rRNA positivity. pfs25 and PF3D7_0630000 RT-PCRs 
were performed and demonstrated a period of gametocyte (Gams)-specific mRNA positivity during the secondary wave of 18S rRNA positivity, 
consistent with gametocytaemia. The 18S rRNA-based results were unaffected by DNase treatment (not shown). Stage-specific 18S rRNA conver-
sion factors were used to estimate parasite densities (7.4 × 103 copies of 18S rRNA/asexual ring left of vertical line; 4.5 × 104 copies of 18S rRNA/
mature gametocyte right of vertical line) and standard curve of pure cultured gametocytes diluted into whole blood was used for quantification 
of gametocyte-specific qRT-PCRs. Primaquine (PQ, 45 mg oral) was administered one time 45 days post-challenge. ND, not detected; asterisk pfs25 
RT-PCR not performed
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Since PF3D7_0630000 was the most promising tar-
get, it was intended to be compared against RT-PCR 
assays for pfs25 and for three other known spliced 
gametocyte-expressed mRNAs: PF3D7_0816800, 
PF3D7_1477700 and PF3D7_1438800. However, two of 
the intended comparator targets could not be multiplexed 
Table 3 Example cycle thresholds for PF3D7_0630000 and published gametocyte-specific RT-PCRs
ND not detected
RT‑PCR target (annealing temp.) Asexual Gametocyte 3 × 106 g/mL Negative control
4 × 105 p/mL 8 × 102 p/mL
PF3D7_0630000 (50 °C) ND ND 23.02 ND
PF3D7_0816800 (50 °C) ND ND 24.98 ND
PF3D7_1477700 (50 °C) 31.96 ND 25.99 ND
PF3D7_1477700 (60 °C) 31.67 38.74 26.50 ND
PF3D7_1438800 (50 °C) 35.42 ND 24.94 ND
PF3D7_1438800 (60 °C) 33.48 ND 25.51 ND
pfs25 (50 °C, DNased template) ND ND 17.67 ND
Plasmodium 18S rRNA 14.91 23.82 10.20 ND
Table 4 Performance of gametocyte-specific RT-PCR markers against field samples from Uganda
Sensitivity = true positive/(true positive + false negative)
Specificity = true negative/(true negative + false positive)
Gametocytes/mL quantities were based on pfs25 standard curve
Gametocytes/mL n pfs25 PF3D7_0630000 PF3D7_0816800
Sensitivity (95% CI)
 1–100 (n = 20) 20 100% (83.2–100.0%) 95.0% (75.1–99.9%) 40.0% (19.1–64.0%)
 101–1000 (n = 13) 13 100% (75.3–100.0%) 100.0% (75.3–100.0%) 61.5% (31.6–86.1%)
 >1000 (n = 14) 14 100% (76.8–100.0%) 100.0% (76.8–100.0%) 100.0% (76.8–100.0%)
 All samples (n = 74) 74 100% (92.5–100.0%) 97.9% (88.7–100.0%) 63.8% (48.5–77.3%)
Specificity (95% CI)
 All samples (=74) 74 100% (87.2–100.0%) 85.2% (66.3–95.8%) 100.0% (87.2–100.0%)
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Fig. 7 Detection of gametocyte-specific markers in Ugandan field samples. a Sensitivity analysis of candidate multiplexed 18S rRNA and gameto-
cyte-specific RT-PCRs as compared to a multiplex assay for 18S rRNA and pfs25 mRNA. Results based on 74 samples from asymptomatic subjects.  
b Specificity analysis of the same samples. Data is in Additional file 3
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with the 18S rRNA RT-PCR assay and were therefore not 
studied against PF3D7_0630000. These targets produced 
positive results when tested against microscopically-pure 
asexual stage cultures (that were also pfs25-negative). 
The extraction method and RT-PCR mastermix used 
here differed from that originally reported for these 
markers [27], which may account for discrepancies. In 
addition, unlike the other targets studied in this project, 
the PF3D7_1477700 and PF3D7_1438800 mRNAs were 
both male gametocyte-specific [37], which could have led 
to false positives in asexual samples if male gametocytes 
(or less apparent exflagellated forms) were present at 
minuscule concentrations in asexual cultures; such forms 
would also be pfs25-negative. While PF3D7_1477700 and 
PF3D7_1438800 mRNAs may be suitable for multiplex-
ing with 18S rRNA in another extraction/mastermix sys-
tem, this possibility was not further evaluated here.
The PF3D7_0630000 multiplex RT-PCR was compa-
rably sensitive to pfs25 when tested against a samples 
from asymptomatic Ugandan subjects. Given this per-
formance, PF3D7_0630000 RT-PCR will be able to detect 
gametocytes at densities that contribute to transmission, 
although this should be studied in future in prospective 
studies. Interestingly, PF3D7_0630000-derived gameto-
cyte density estimates were 1.18  log10 higher on average 
than pfs25-based estimates, which likely reflects degra-
dation of pfs25 mRNA (but not more robust 18S rRNA) 
during the DNase treatment step. Detection of pfs25 
mRNA by QT-NASBA (which does not require DNase 
treatment) was reportedly more sensitive than pfs25 RT-
PCR, and the authors postulated that the DNase treat-
ment step could have reduced the sensitivity of pfs25 
RT-PCR [12]. Thus, it is likely that the increased sensitiv-
ity of pfs25 RT-PCR (due to its increased expression) is 
somewhat offset by increased degradation at the DNase 
treatment step.
By eliminating DNase treatment, gametocyte-specific 
RT-PCR targets can be directly incorporated into multi-
plex RT-PCR assays from total nucleic acids. This impor-
tance of this workflow improvement may be significant. 
Although ‘on-column’ DNase treatment is available for 
some manual RNA purification kits, this was not an 
option for the platform used here (Abbott m2000sp/rt 
[22]. Elimination of DNase treatment would be advan-
tageous. In epidemiological studies, simplified sample 
processing that minimizes hands-on time and eliminates 
manual steps are desirable since extra steps serve to 
increase false positive and negative results through cross-
contamination, target degradation and other process-
ing errors. The use of spliced gametocyte-specific 
mRNAs such as those identified here (PF3D7_0630000 
and PF3D7_0514500) or those reported previously [26, 
27] offer the possibility of this sort of simplified testing. 
Other spliced mRNA targets beyond these may also be 
suitable for RT-PCR. Similarly, spliced mRNA RT-PCR 
may also be useful for detecting asexual stage-specific 
spliced mRNAs such as the ring-specific transcript from 
the two-exon PF3D7_0501300 (PFE0065w) gene previ-
ously used as an asexual parasite marker [27]. Multiplex 
assays that include the Plasmodium 18S rRNA, a spliced 
gametocyte-specific mRNA and a spliced ring/asexual-
specific mRNA could eventually provide for one-step P. 
falciparum infection monitoring that would differenti-
ate between potentially symptomatic and asymptomatic 
infections. The PF3D7_0630000-specific spliced marker 
identified here may be useful in future gametocyte 
screening studies.
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